258 related articles for article (PubMed ID: 15503665)
21. An evaluation of endocrine modulators: implications for human health.
Juberg DR
Ecotoxicol Environ Saf; 2000 Feb; 45(2):93-105. PubMed ID: 10648129
[TBL] [Abstract][Full Text] [Related]
22. Human exposure to endocrine disrupters: standardisation of a marker of estrogenic exposure in adipose tissue.
Rivas A; Fernandez MF; Cerrillo I; Ibarluzea J; Olea-Serrano MF; Pedraza V; Olea N
APMIS; 2001 Mar; 109(3):185-97. PubMed ID: 11430496
[TBL] [Abstract][Full Text] [Related]
23. Uncertainties for endocrine disrupters: our view on progress.
Daston GP; Cook JC; Kavlock RJ
Toxicol Sci; 2003 Aug; 74(2):245-52. PubMed ID: 12730617
[TBL] [Abstract][Full Text] [Related]
24. Identification and assessment of endocrine disruptors: limitations of in vivo and in vitro assays.
Zacharewski T
Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):577-82. PubMed ID: 9599705
[TBL] [Abstract][Full Text] [Related]
25. Gene expression changes induced in the testis by transplacental exposure to high and low doses of 17{alpha}-ethynyl estradiol, genistein, or bisphenol A.
Naciff JM; Hess KA; Overmann GJ; Torontali SM; Carr GJ; Tiesman JP; Foertsch LM; Richardson BD; Martinez JE; Daston GP
Toxicol Sci; 2005 Aug; 86(2):396-416. PubMed ID: 15901920
[TBL] [Abstract][Full Text] [Related]
26. The immune system of geriatric mice is modulated by estrogenic endocrine disruptors (diethylstilbestrol, alpha-zearalanol, and genistein): effects on interferon-gamma.
Calemine J; Zalenka J; Karpuzoglu-Sahin E; Ward DL; Lengi A; Ahmed SA
Toxicology; 2003 Dec; 194(1-2):115-28. PubMed ID: 14636701
[TBL] [Abstract][Full Text] [Related]
27. Endocrine disrupters in the aquatic environment: the Austrian approach--ARCEM.
Bursch W; Fuerhacker M; Gemeiner M; Grillitsch B; Jungbauer A; Kreuzinger N; Moestl E; Scharf S; Schmid E; Skutan S; Walter I
Water Sci Technol; 2004; 50(5):293-300. PubMed ID: 15497860
[TBL] [Abstract][Full Text] [Related]
28. Transcriptome alterations in zebrafish embryos after exposure to environmental estrogens and anti-androgens can reveal endocrine disruption.
Schiller V; Wichmann A; Kriehuber R; Schäfers C; Fischer R; Fenske M
Reprod Toxicol; 2013 Dec; 42():210-23. PubMed ID: 24051129
[TBL] [Abstract][Full Text] [Related]
29. OECD test strategies and methods for endocrine disruptors.
Gelbke HP; Kayser M; Poole A
Toxicology; 2004 Dec; 205(1-2):17-25. PubMed ID: 15458786
[TBL] [Abstract][Full Text] [Related]
30. Oral p-tert-octylphenol exposures induce minimal toxic or estrogenic effects in adult female Sprague-Dawley rats.
Sahambi SK; Pelland A; Cooke GM; Schrader T; Tardif R; Charbonneau M; Krishnan K; Haddad S; Cyr DG; Devine PJ
J Toxicol Environ Health A; 2010; 73(9):607-22. PubMed ID: 20391140
[TBL] [Abstract][Full Text] [Related]
31. Pharmaco- and toxicokinetics of selected exogenous and endogenous estrogens: a review of the data and identification of knowledge gaps.
Mattison DR; Karyakina N; Goodman M; LaKind JS
Crit Rev Toxicol; 2014 Sep; 44(8):696-724. PubMed ID: 25099693
[TBL] [Abstract][Full Text] [Related]
32. [Bisphenol.alkylphenols].
Hirose A; Koizumi M; Hasegawa R
Nihon Rinsho; 2000 Dec; 58(12):2428-33. PubMed ID: 11187732
[TBL] [Abstract][Full Text] [Related]
33. Identification of estrogen-regulated genes by microarray analysis of the uterus of immature rats exposed to endocrine disrupting chemicals.
Hong EJ; Park SH; Choi KC; Leung PC; Jeung EB
Reprod Biol Endocrinol; 2006 Sep; 4():49. PubMed ID: 17010207
[TBL] [Abstract][Full Text] [Related]
34. Validation study of OECD rodent uterotrophic assay for the assessment of estrogenic activity in Sprague-Dawley immature female rats.
Kim HS; Kang TS; Kang IH; Kim TS; Moon HJ; Kim IY; Ki H; Park KL; Lee BM; Yoo SD; Han SY
J Toxicol Environ Health A; 2005 Dec; 68(23-24):2249-62. PubMed ID: 16326438
[TBL] [Abstract][Full Text] [Related]
35. The screening of chemicals for juvenoid-related endocrine activity using the water flea Daphnia magna.
Wang HY; Olmstead AW; Li H; Leblanc GA
Aquat Toxicol; 2005 Sep; 74(3):193-204. PubMed ID: 16046008
[TBL] [Abstract][Full Text] [Related]
36. Screening chemicals for thyroid-disrupting activity: A critical comparison of mammalian and amphibian models.
Pickford DB
Crit Rev Toxicol; 2010 Nov; 40(10):845-92. PubMed ID: 20684730
[TBL] [Abstract][Full Text] [Related]
37. An exposure:activity profiling method for interpreting high-throughput screening data for estrogenic activity--proof of concept.
Becker RA; Friedman KP; Simon TW; Marty MS; Patlewicz G; Rowlands JC
Regul Toxicol Pharmacol; 2015 Apr; 71(3):398-408. PubMed ID: 25656492
[TBL] [Abstract][Full Text] [Related]
38. Development of phenotypic and transcriptional biomarkers to evaluate relative activity of potentially estrogenic chemicals in ovariectomized mice.
Hewitt SC; Winuthayanon W; Pockette B; Kerns RT; Foley JF; Flagler N; Ney E; Suksamrarn A; Piyachaturawat P; Bushel PR; Korach KS
Environ Health Perspect; 2015 Apr; 123(4):344-52. PubMed ID: 25575267
[TBL] [Abstract][Full Text] [Related]
39. Vitellogenin synthesis in primary cultures of fish liver cells as endpoint for in vitro screening of the (anti)estrogenic activity of chemical substances.
Navas JM; Segner H
Aquat Toxicol; 2006 Oct; 80(1):1-22. PubMed ID: 16950525
[TBL] [Abstract][Full Text] [Related]
40. Endocrine disrupters. Panel cautiously confirms low-dose effects.
Kaiser J
Science; 2000 Oct; 290(5492):695-7. PubMed ID: 11184192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
